🇺🇸 FDA
Pipeline program

CMGV

CMG-sAML-001

Unknown small_molecule active

Quick answer

CMGV for Recurrent Adult Acute Myeloid Leukemia is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Recurrent Adult Acute Myeloid Leukemia
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials